Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice (PREDICT), Randomized Control Trial

NCT06872346 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06872346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06872346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice (PREDICT), Randomized Control Trial
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 22, 2026
Completion date
January 22, 2029
Enrollment
7,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer screening